FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10

Medroxyprogesterone acetate

Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Date of authorisation: 23/01/2006, Revision: 20, Status: Authorised

Organisation chart: Information Management

Successful pilot paves the way for implementation of ePI

Electronic product information (ePI) report: Experience gained from creation of ePI during regulatory procedures for EU human medicines

Union list of critical medicines - version 2

Human medicines European public assessment report (EPAR): Vedrop, tocofersolan, Date of authorisation: 23/07/2009, Revision: 14, Status: Authorised

Procedural advice for post-orphan medicinal product designation activities: Guidance for sponsors

Applying for orphan designation